Respiratory viruses continue to pose significant public health challenges globally, including influenza viruses, coronaviruses etc. While existing vaccines have made substantial progress in protecting populations, the rapid mutation of viruses and the emergence of new pathogens continuously drive innovation in vaccine development.

In this webinar, we will explore novel vaccine types and their mechanisms. We will review key factors affecting linear mRNA stability and protein expression, and delve into circular RNA and self-amplifying RNA (saRNA) as alternative approaches. Additionally, we will discuss peptide libraries, which are vital tools in vaccine development. Through these discussions, participants will gain a deeper understanding of cutting-edge research in novel respiratory virus vaccines.

Learning Objectives: 

1. Novel vaccine types and mechanism.

2. Differences among linear mRNA, circular RNA and saRNA.

3. Peptide library types used for vaccine development.